Incidence of recurrent VTE1 after initial treatment (up to 15 days) · patients with venous thromboembolism.
LMWH probably leads to lower incidence of recurrent VTE1 after initial treatment (up to 15 days) compared with UFH (moderate certainty).
1 finding from 1 review
Major bleeding · patients with venous thromboembolism.
LMWH probably leads to lower incidence of major haemorrhagic episodes (during initial treatment ‐… compared with UFH (moderate certainty).
1 finding from 1 review
Mean days in treatment · Adults with opioid dependence
1 finding from 1 review
Mean days in treatment (with varying scheduled duration) · Adults or adolescents with opioid dependence
Buprenorphine probably leads to higher mean days in treatment (with varying scheduled duration) compared with alpha2‐adrenergic agonists (moderate certainty).
1 finding from 1 review
Intervention not reported
Length of NICU stay (days) · neonates requiring intubation and ventilation
1 finding from 1 review
Intervention not reported
Poor neurological outcome by 28 days' postnatal age · neonates requiring intubation and ventilation
The intervention showed no clear difference in poor neurological outcome by 28 days' postnatal age (moderate certainty).
1 finding from 1 review
Intervention not reported
Poor neurological outcome by 28 days' postnatal age · neonates requiring intubation and ventilation
The intervention probably leads to higher poor neurological outcome by 28 days' postnatal age (moderate certainty).
1 finding from 1 review
Intervention not reported
BPD at 28 days · Preterm neonates with respiratory distress
The intervention showed no clear difference in BPD at 28 days (low certainty).
1 finding from 1 review
Death or BPD (28 days) · preterm infants with respiratory distress for initial respiratory support
Inhaled steroids showed no clear difference in death or BPD at 28 days compared with systemic corticosteroids (low certainty).
1 finding from 1 review
BPD at 28 days · preterm infants with respiratory distress for initial respiratory support
Inhaled steroids showed no clear difference in BPD at 28 days compared with systemic corticosteroids (low certainty).
1 finding from 1 review
Intervention not reported
Duration of mechanical ventilation (days) · Preterm neonates with respiratory distress
1 finding from 1 review
Intervention not reported
Duration of supplemental oxygen (days) · Preterm neonates with respiratory distress
1 finding from 1 review
Intervention not reported
Mortality or CLD at 28/30 days · preterm infants
The intervention showed no clear difference in mortality or CLD at 28/30 days (low certainty).
1 finding from 1 review
Intervention not reported
Mortality to 28 days · preterm infants
It is very uncertain whether the intervention changes mortality to 28 days (very low certainty).
1 finding from 1 review
Intervention not reported
CLD at 28 days · preterm infants
The intervention showed no clear difference in CLD at 28 days (low certainty).
1 finding from 1 review
Intervention not reported
CLD among survivors to 28 days · preterm infants
The intervention showed no clear difference in CLD among survivors to 28 days (low certainty).
1 finding from 1 review
Intervention not reported
Days on mechanical ventilation · preterm infants
1 finding from 1 review
Number of episodes of regurgitation or vomiting per day · Formula‐fed healthy term infants up to 6 months of age with gastro‐oesophageal reflux
1 finding from 1 review
BPD at 28 days · neonates up to 44 weeks' postmenstrual age
Volume‐targeted showed no clear difference in BPD (supplemental oxygen at 28 days) compared with pressure‐limited ventilation: additional findings (low certainty).
1 finding from 1 review
Duration of positive pressure ventilation (days) · neonates up to 44 weeks' postmenstrual age
1 finding from 1 review